About Promis Diagnostics
Promis Diagnostics is a company based in Pasadena (United States) founded in 2019.. Promis Diagnostics has raised $10.8 million across 1 funding round from investors including KB Investment and Solidus Investment. The company has 9 employees as of December 31, 2021. Promis Diagnostics offers products and services including EarlyTect BCD and COVID-19 and Flu Testing. Promis Diagnostics operates in a competitive market with competitors including Viome, Invitae, Color, Everlywell and IGM Biosciences, among others.
- Headquarter Pasadena, United States
- Employees 9 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Promis Diagnostics, Inc.,
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.8 M (USD)
in 1 rounds
-
Latest Funding Round
$10.8 M (USD), Series A
Jan 20, 2020
-
Investors
KB Investment
& 1 more
-
Employee Count
9
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Promis Diagnostics
Promis Diagnostics offers a comprehensive portfolio of products and services, including EarlyTect BCD and COVID-19 and Flu Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Noninvasive urine test for early bladder cancer detection with high accuracy.
Tests for detecting viral infections using biomarker-based methods.
Funding Insights of Promis Diagnostics
Promis Diagnostics has successfully raised a total of $10.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.8 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.8M
-
First Round
First Round
(20 Jan 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series A - Promis Diagnostics | Valuation | KB Investment , Solidus Investment |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Promis Diagnostics
Promis Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include KB Investment and Solidus Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in early-stage tech startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Promis Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Promis Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Promis Diagnostics Comparisons
Competitors of Promis Diagnostics
Promis Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Color, Everlywell and IGM Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| domain | founded_year | HQ Location |
Antibodies for cancer and infectious disease treatments are developed.
|
|
| domain | founded_year | HQ Location |
Personalized therapeutics are developed using genomic data for rare diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Promis Diagnostics
When was Promis Diagnostics founded?
Promis Diagnostics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Promis Diagnostics located?
Promis Diagnostics is headquartered in Pasadena, United States. It is registered at Pasadena, California, United States.
Is Promis Diagnostics a funded company?
Promis Diagnostics is a funded company, having raised a total of $10.8M across 1 funding round to date. The company's 1st funding round was a Series A of $10.8M, raised on Jan 20, 2020.
How many employees does Promis Diagnostics have?
As of Dec 31, 2021, the latest employee count at Promis Diagnostics is 9.
What does Promis Diagnostics do?
Promis Diagnostics was founded in 2019 in Pasadena, United States, focusing on biotechnology for cancer detection. Non-invasive diagnostic platforms are being developed to identify biomarkers such as DNA methylation and DNA repair genes. Stool-based tests are utilized for colorectal cancer screening. Operations center on advancing these technologies to support early detection in the medical diagnostics sector.
Who are the top competitors of Promis Diagnostics?
Promis Diagnostics's top competitors include Viome, IGM Biosciences and Variant Bio.
What products or services does Promis Diagnostics offer?
Promis Diagnostics offers EarlyTect BCD and COVID-19 and Flu Testing.
Who are Promis Diagnostics's investors?
Promis Diagnostics has 2 investors. Key investors include KB Investment, and Solidus Investment.